Tags |
|
|
Links |
|
|
Advice You - Web Analytics for All
In the Internet market, every day we face new challenges and no one is out
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
of this game, not even giants as Google and Yahoo, who as others, have al
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
so the necessity of finding a trustful and competitive web analytics tool.
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
Many of you know that one of the Google's weakest links has always been
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
the web analytics, in opposition to his closest competitor Overture (owned
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
by Yahoo), who 3 years ago acquired KeyLime (a web analytics software com
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
pany) for its own usage. As a step ahead, Google recently announced the pu
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
rchase of Urchin, in order to compete with Overture offering a better stat
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
istics option to their customers.
In the other hand, we have a well known
In the other hand, we have a well known
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
participant called WebTrends, who had been sold by NetIQ after only 3 yea
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
rs since they acquired it; why? We didn't find a specific reason however i
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
t seems to be that their clients were not satisfied by the given support s
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ervice, plus the hard competence from other players as ClickTracks, who re
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
leased the ClickTracks Professional edition, were strong reasons to determ
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ine its sale.
As from my own experience I've seen that ClickTracks, being
As from my own experience I've seen that ClickTracks, being
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
an independent vendor, is constantly working on new products such as thei
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
r new release: ClickTracks Optimizer (great for mid/large size web sites),
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
and adding to the existing ClickTracks Analyzer and Pro editions new mark
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
eting oriented features and upgrades options, in order to satisfy their cu
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
stomers around the world and assist them while taking important decisions.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/50871/adviceyou-Web-Analytics-for-All.html">Web Analytics for All</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/50871/adviceyou-Web-Analytics-for-All.html]Web Analytics for All[/url]
Related Articles:
Study Proves That Headline Length Can Impact Profitability!
How To Set a Job Interview and Get Hired Fast - By Addressing Gaps In Your Resume
Bookmark it:
|